Research & Development



  蛋頭說的每一個字他都不信!   貓戲老鼠不是劉徹的性格,站在大漢朝的最高位置上,他沒有時間去玩陰謀,他更加的喜歡斬草除根。五月婷婷久久大香蕉   司馬遷守在桌案前面,看何愁有寫梅花篆字看的如痴如醉,嘴里還不住地念叨︰“好一個縱死猶聞俠骨香!好一個縱死猶聞俠骨香!老祖宗這梅花篆字的架構疏密結合,頗有鐵鉤銀劃之妙,僅僅是這個死字組成的梅花,不但讓人見識不到死亡的寂寥,反而有一種勃勃生機蘊含其中,妙,妙,大妙!”色综合   霍去病輕笑一聲道︰“如果砍掉你的腦袋能夠讓我大軍找到正確的道路,我並不介意這麼做,只是殺了你也沒用,畢竟,人力有窮時!”   雲瑯牽著甦稚的手去了傷兵營,他自然知道甦稚來他這里的意思,就是想要他陪著她去看看巴澤爾到底屈服了沒有。久久综合   “陛下也會梅花篆字?”

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo